Dr. Stylianos Michalakis

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Stylianos Michalakis. Improve your application with a focused, well-structured draft.

Biography

Prof. Stylianos Michalakis leads the Ocular Gene Therapy Research Group at the University Hospital LMU Munich. His research focuses on genetic and gene therapy approaches for ocular diseases. With his team, he has pioneered the development of optimized viral vectors for treating inherited and age-related retinal diseases. Notably, he contributed to the first-ever gene therapy clinical trial for CNGA3-related achromatopsia, published in JAMA Ophthalmology 2020. His group is also involved in ongoing clinical trials for PDE6A-related retinitis pigmentosa and other gene therapy projects funded by NIH and DFG. He has over 130 scientific publications, showcasing his expertise in genetics and molecular mechanisms of retinal diseases. The research group is well-supported by national and international grants, reflecting its impact in the field of ophthalmology.

Research Interests

Gene Therapy Ocular Genetics Retinal Diseases Molecular Mechanisms of Degenerative Diseases

Experience

Professor

2015-01-01 — Present

Ludwig Maximilian University of Munich • Munich, Germany

Leading the Ocular Gene Therapy Research Group, focusing on gene therapy for retinal diseases.

Requirements for Ludwig Maximilian University of Munich

Master Program
Requirements
GPA Requirement
Required:2.5
TOEFL
Total
Required:80
IELTS
Overall
Required:6.5
Prerequisites
Bachelor's degree in Economics or related quantitative field At least 75% of Bachelor's curriculum completed at time of application
Application Checklist
  • Curriculum Vitae in English
  • Motivation letter (2000-3000 characters)
  • Bachelor's degree certificate and transcript
  • Explanation of grading scale
  • Proof of English proficiency
Specialization Notes

Administered by the Faculty of Economics. GRE is NOT required for the standard M.Sc. Economics.